| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 20 May 2025 | 15 May 2025 |
| Gujarat Inject Kerala Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve consideration & approval of Audited Financial Results. AUDITED FINANCIAL RESULTS 31.03.2025 (As Per BSE Announcement Dated on: 20/05/2025) | ||
| Board Meeting | 18 Feb 2025 | 13 Feb 2025 |
| GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/02/2025 inter alia to consider and approve proposal for sub- division/split of the equity shares of the Company in such manner as may be determined by the Board of Directors and subject to approval of the Shareholders and such authorities as may be required Outcome of the Board Meeting held on Tuesday 18th February, 2025 1. Approved Stock-split/sub-division of each equity share of the Company, having face value of Rs.10/- each, into 1 (One) equity share of face value Re. 1/- each, subject to approval of the shareholders of the Company and other statutory/regulatory authorities, as may be required. In this respect, the record shall be decided by the Board separately which shall be intimated to Exchange in the due course. 2. Approved substitution / alteration in the Main Object Clauses of the Memorandum of Association of the Company subject to approval of the shareholders of the Company in the ensuing Annual General Meeting/Extra Ordinary General Meeting of the Company. 3. Approved the proposed change in name of the Company from Gujarat Inject (Kerala) Limited to Shrikara Enterprise Limited or any other name as may be available and approved by Ministry of Corporate Affairs and consequential alteration in Memorandum of Association and Articles of Association of the Company to give effect to the change of name of the Company, subject to the approval of shareholders of the Company by way of special resolution and other concerned authorities (As Per BSE Announcement Dated on 18.02.2025) | ||
| Board Meeting | 5 Feb 2025 | 1 Feb 2025 |
| GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 inter alia to consider and approve proposal for sub- division/split of the equity shares of the Company in such manner as may be determined by the Board of Directors and subject to approval of the Shareholders and such authorities as may be required Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company, at its meeting held today i.e., Wednesday, 5th February, 2025, could not come to conclusion on the subject matter of Stock Split/sub-division of the equity shares of the company due to some technical and unavoidable circumstances. (As Per Bse Announcement Dated on 05.02.2025) | ||
| Board Meeting | 23 Jan 2025 | 18 Jan 2025 |
| GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 inter alia to consider and approve & take on record the Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and any other items as may be decided by the Board of Directors. In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on January 23, 2025, at the Registered Office of the Company which was commenced at 05:00 P.M. and concluded at 05:20 P.M., have, apart from other businesses, 1) Considered, approved and taken on record the Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2024 along with Limited Review Report (Unmodified Opinion) In this regards, we are hereby submitting the followings: 1. Unaudited Financial Results for the quarter and nine months ended on December 31, 2024; 2. Limited review report; Kindly take the same on your record and oblige us Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2024 along with Limited Review Report (Unmodified Opinion) (As per BSE Announcement Dated on 23/01/2025) | ||
| Board Meeting | 22 Oct 2024 | 7 Oct 2024 |
| GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of our Company is scheduled to be held on Tuesday October 22 2024 at the registered office of the Company situated at Shop No. 15 K-Tower Haveli Resi-Cum Plaza Behind Air Force Station Makarpura Vadodara - 390014 Gujarat India to consider approve & take on record the Unaudited Standalone Financial Results of the Company for the quarter and half year ended on September 30 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and any other items as may be decided by the Board of Directors. In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on October 22, 2024, at the Registered Office of the Company which was commenced at 04:00 P.M. and concluded at 04:40 P.M., have, apart from other businesses, 1) Considered, approved and taken on record the Unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2024 along with Limited Review Report (Unmodified Opinion) In this regards, we are hereby submitting the followings: 1. Unaudited Financial Results for the quarter and half year ended on September 30, 2024; 2. Limited review report; Read less.. Unaudited Financial Result of the Company for the quarter and half year ended on September 30, 2024 along with Limited Review Report (Unmodified Opinion) (As Per BSE Announcement Dated on 22.10.2024) | ||
| Board Meeting | 10 Aug 2024 | 2 Aug 2024 |
| GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2024 inter alia to consider and approve take on record the Unaudited Standalone Financial Results of the Company for the quarter ended on June 30 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and any other items as may be decided by the Board of Directors. we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on August 10, 2024, at the Registered Office of the Company which was commenced at 03:15 P.M. and concluded at 03:40 P.M (As Per BSE Announcement Dated on: 10/08/2024) | ||
| Board Meeting | 10 Jun 2024 | 10 Jun 2024 |
| Appointed Ms. Manmeetkaur Harshdeepsingh Bhatia as a Company Secretary and Compliance Officer of the Company with effect from June 10, 2024. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.